Literature DB >> 1169093

Myocardial infarction in young women with special reference to oral contraceptive practice.

J I Mann, M P Vessey, M Thorogood, S R Doll.   

Abstract

Sixty-three women discharged from hospital with a diagnosis of myocardial infarction and 189 control patients were studied. All were under 45 years of age at the time of admission. Current oral contraceptive use, heavy cigarette smoking, treated hypertension and diabetes, pre-eclamptic toxaemia, and obesity were all reported by, and type II hyperlipoproteinaemia was found more often in, patients with myocardial infarction than their controls. The relationship between myocardial infarction and oral contraceptives could not be explained in terms of an association between the use of these preparations and the other factors. The combined effect of the risk factors was clearly synergistic.

Entities:  

Keywords:  Biology; Cardiovascular Effects; Clinical Research; Contraception; Contraceptive Methods--side effects; Diseases; Family Planning; Heart Diseases--etiology; High Risk Women; Lipid Metabolic Effects; Lipids; Oral Contraceptives--side effects; Physiology; Research Methodology; Retrospective Studies; Studies

Mesh:

Substances:

Year:  1975        PMID: 1169093      PMCID: PMC1673246          DOI: 10.1136/bmj.2.5965.241

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

Review 1.  Thromboembolism, cancer, and oral contraceptives.

Authors:  M P Vessey
Journal:  Clin Obstet Gynecol       Date:  1974-03       Impact factor: 2.190

2.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study.

Authors:  L A Carlson; L E Böttiger
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

3.  Serum-lipids in women on oral contraceptives.

Authors:  T Stokes; V Wynn
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

4.  Smoking habits of oral contraceptive users.

Authors:  C R Kay; A Smith; B Richards
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

5.  Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin.

Authors:  U Goldbourt; J H Medalie
Journal:  Br J Prev Soc Med       Date:  1974-05

6.  Characteristics of women using different methods of contraception--some preliminary findings from a prospective study.

Authors:  M P Vessey; R Doll; R Peto; G Redman
Journal:  Int J Epidemiol       Date:  1972       Impact factor: 7.196

7.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon; P M McNamara
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

8.  Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.

Authors:  W H Inman; M P Vessey; B Westerholm; A Engelund
Journal:  Br Med J       Date:  1970-04-25

9.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

Authors:  W H Inman; M P Vessey
Journal:  Br Med J       Date:  1968-04-27

10.  Ischaemic heart disease in young women.

Authors:  M F Oliver
Journal:  Br Med J       Date:  1974-11-02
View more
  35 in total

Review 1.  Estrogen therapies, lipids, and the heart disease prevention controversy.

Authors:  Robert H Knopp; Keiko Aikawa; Eleanor A Knopp
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

2.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

3.  Effects of estrogens and progestins on high density lipoproteins.

Authors:  R M Krauss; F T Lindgren; J Wingerd; D D Bradley; S Ramcharan
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

Review 4.  A woman's heart. An update of coronary artery disease risk in women.

Authors:  D A Leaf
Journal:  West J Med       Date:  1988-12

Review 5.  [Desogestrel contraceptives: the perfect pill for lipids?].

Authors:  L Laurendeau
Journal:  Can Fam Physician       Date:  1996-01       Impact factor: 3.275

Review 6.  Hormonal steroid contraceptives: a further review of adverse reactions.

Authors:  E G McQueen
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

7.  Clinical implications of Surgeon General's Report on Smoking and Health.

Authors: 
Journal:  J Natl Med Assoc       Date:  1979-07       Impact factor: 1.798

8.  Anti-oestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus.

Authors:  R Bucala; R G Lahita; J Fishman; A Cerami
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Prevalence of three major risk factors in random sample of men and women, and in patients with ischaemic heart disease.

Authors:  T B Dick; M C Stone
Journal:  Br Heart J       Date:  1978-06

10.  Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects.

Authors:  G D Lowe; J E Thomson; M M Reavey; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.